The guest speaker, Claus, who is the Chief Commercial Officer of Astellas, a global pharma company, discusses the history of pharmaceutical innovation in areas like cancer oncology and transplant mechanics. The discussion focuses on how the pharmaceutical industry has contributed to improving patient well-being over the years. The host and Claus delve into the future of pharmaceutical innovation, particularly in the next 10 years, where they anticipate significant advancements in biological and digital convergence. They highlight the potential of gene and cell therapies and mRNA technologies to revolutionize medical treatments. Additionally, they explore the impact of digitalization on drug development, patient interactions, and the healthcare system as a whole.
